The Mergers and Acquisitions (M&A) landscape in Vietnam's pharmaceutical sector has seen new developments as Lian SGP Holding Pte. Ltd... Read more
Tag: #M&A
Novartis Completes $12 Billion Acquisition of Avidity Biosciences
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has officially announced the completion of its acquisition of Avidity Biosciences, Inc., which... Read more
GSK acquires 35Pharma to challenge for leadership in pulmonary hypertension market
On February 25, 2026, GSK reached an agreement to acquire the Canadian biotech firm 35Pharma for $950 million. The centerpiece... Read more
Gilead acquires CAR-T specialist Arcellx for $7.8bn to strengthen cell therapy dominance
Gilead Sciences has entered into a definitive agreement to acquire Arcellx in a deal valued at $7.8 billion. Under the... Read more
Ampersand Capital Acquires Purna Pharmaceuticals to Forge Trans-Atlantic Partnership
On February 13, 2026, Ampersand Capital Partners completed the acquisition of Purna Pharmaceuticals, a Belgium-based CDMO specializing in liquid and... Read more
Eli Lilly acquires Orna Therapeutics to pioneer ‘in vivo’ cell therapy era
Eli Lilly has officially announced the acquisition of Orna Therapeutics, a biotech startup specializing in re-engineering immune cells directly inside... Read more
Kuva Labs Acquires Lisata Therapeutics to Expand Cancer Diagnostic and Therapeutic Pipeline
Kuva Labs, a specialist in cancer imaging, has entered into a binding agreement to acquire Lisata Therapeutics, a biotech firm... Read more
GSK acquires RAPT Therapeutics for $2.2B to strengthen food allergy pipeline
GSK has entered into a definitive agreement to acquire California-based RAPT Therapeutics for $58.00 per share, representing a total equity... Read more
Verana Health acquires COTA Healthcare to lead RWD analytics market
Merger & Acquisition Update Verana Health, a real-world data (RWD) analytics firm, has announced the acquisition of oncology specialist COTA... Read more









